What Is the Procedure for Using the Manufacturing Facilities at the National Center for Stem Cell and Regenerative Medicine?

National Institute of Health Publishes Q&A Guide on Manufacturing Support for Clinical-Grade Cell Therapies

The National Institute of Health has published the “Q&A Guide on the GMP Manufacturing Facilities of the National Center for Stem Cell and Regenerative Medicine,” compiling key questions and answers collected from researchers in the field of regenerative medicine.

The guide contains a total of 37 frequently asked questions and answers related to support for the manufacturing and quality testing of clinical-grade stem cell therapies.

The content is organized into five categories: General Information, Manufacturing Processes, Quality Control, Quality Assurance, and Storage Management.



Park Hyun-young, Director of the National Institute of Health, said, “We hope this Q&A guide will improve understanding among researchers and organizations seeking to use the GMP manufacturing facilities of the National Center for Stem Cell and Regenerative Medicine and provide practical support for the commercialization of regenerative medicine.”

The Q&A guide is available through the National Center for Stem Cell and Regenerative Medicine website so that anyone can easily access and use the information.

Source: Medworld News